11/08/2016 - 12:19pm

The companies believe their submission has the potential to be the first of a proposed biosimilar for the drug in the United States. 

11/07/2016 - 1:36pm

Teva has gotten approval from the Food and Drug Administration for two generics of high blood pressure drugs, one of which it has launched. 

11/07/2016 - 1:21pm
Ajanta’s generic will be available in 50- and 200-mg dosage strengths. 
11/07/2016 - 1:04pm

Endo has announced the appointment of two key executive leadership team members, naming Terrance J. Coughlin its EVP and COO, and adding Tony Pera as the president of Endo’s U.S. generics company Par Pharmaceutical. 

11/07/2016 - 12:27pm

The company will collaborate with Bluepharma to develop and distribute a generic product in a category with U.S. sales more than $75 million, according to QuintilesIMS data for the 12 months ended July 2016. 

11/04/2016 - 11:51am

Camber Pharmaceuticals on Thursday announced the launch of its generics of Avodart (dutasteride) capsules and Levaquin (levofloxacin) tablets.

11/02/2016 - 11:27am
The contraceptive had U.S. sales of $178.2 million for the 12 months ended June 2016, according to QuintilesIMS data. 
11/02/2016 - 11:20am

Ajanta has launched its generic of Azor, a high blood pressure treatment. 

11/01/2016 - 11:45am

The drug  had U.S. sales of $911 million for the 12 months ended September 2016, according to QuintilesIMS data.